Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118663806 | 11866380 | 6 | F | 2012 | 20160908 | 20151224 | 20160915 | EXP | CA-ROCHE-1680862 | ROCHE | 69.44 | YR | F | Y | 57.00000 | KG | 20160915 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118663806 | 11866380 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0078,S0062,S0066B,S0003B | 103976 | 300 | MG | SOLUTION FOR INJECTION | ||||||
| 118663806 | 11866380 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0078,S0062,S0066B,S0003B | 103976 | 300 | MG | SOLUTION FOR INJECTION | /month | |||||
| 118663806 | 11866380 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0078,S0062,S0066B,S0003B | 103976 | 300 | MG | SOLUTION FOR INJECTION | /month | |||||
| 118663806 | 11866380 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0078,S0062,S0066B,S0003B | 103976 | SOLUTION FOR INJECTION | ||||||||
| 118663806 | 11866380 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0078,S0062,S0066B,S0003B | 103976 | SOLUTION FOR INJECTION | ||||||||
| 118663806 | 11866380 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0078,S0062,S0066B,S0003B | 103976 | 300 | MG | SOLUTION FOR INJECTION | ||||||
| 118663806 | 11866380 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0078,S0062,S0066B,S0003B | 103976 | 600 | MG | SOLUTION FOR INJECTION | ||||||
| 118663806 | 11866380 | 8 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0078,S0062,S0066B,S0003B | 103976 | 300 | MG | SOLUTION FOR INJECTION | ||||||
| 118663806 | 11866380 | 9 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | U | 0 | ||||||||||
| 118663806 | 11866380 | 10 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 118663806 | 11866380 | 11 | C | NASACORT | TRIAMCINOLONE ACETONIDE | 1 | Unknown | U | 0 | ||||||||||
| 118663806 | 11866380 | 12 | C | ATIVAN | LORAZEPAM | 1 | 0 | ||||||||||||
| 118663806 | 11866380 | 13 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 118663806 | 11866380 | 14 | C | BRICANYL | TERBUTALINE SULFATE | 1 | Unknown | U | 0 | ||||||||||
| 118663806 | 11866380 | 15 | C | DECADRON | DEXAMETHASONE | 1 | Unknown | U | 0 | ||||||||||
| 118663806 | 11866380 | 16 | C | AMOXIL | AMOXICILLIN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118663806 | 11866380 | 1 | Asthma |
| 118663806 | 11866380 | 9 | Product used for unknown indication |
| 118663806 | 11866380 | 10 | Product used for unknown indication |
| 118663806 | 11866380 | 11 | Product used for unknown indication |
| 118663806 | 11866380 | 13 | Product used for unknown indication |
| 118663806 | 11866380 | 14 | Product used for unknown indication |
| 118663806 | 11866380 | 15 | Product used for unknown indication |
| 118663806 | 11866380 | 16 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118663806 | 11866380 | HO |
| 118663806 | 11866380 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118663806 | 11866380 | Asthma | |
| 118663806 | 11866380 | Cough | |
| 118663806 | 11866380 | Dyspnoea exertional | |
| 118663806 | 11866380 | Gastroenteritis | |
| 118663806 | 11866380 | Incorrect dose administered | |
| 118663806 | 11866380 | Influenza | |
| 118663806 | 11866380 | Nasal congestion | |
| 118663806 | 11866380 | Nasal discharge discolouration | |
| 118663806 | 11866380 | Nasopharyngitis | |
| 118663806 | 11866380 | Pain | |
| 118663806 | 11866380 | Pruritus | |
| 118663806 | 11866380 | Respiratory tract infection | |
| 118663806 | 11866380 | Tooth infection | |
| 118663806 | 11866380 | Urticaria | |
| 118663806 | 11866380 | Vaginal infection | |
| 118663806 | 11866380 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118663806 | 11866380 | 1 | 20060928 | 0 | ||
| 118663806 | 11866380 | 2 | 20090528 | 0 | ||
| 118663806 | 11866380 | 3 | 20100309 | 0 | ||
| 118663806 | 11866380 | 4 | 20160309 | 0 | ||
| 118663806 | 11866380 | 5 | 20160505 | 0 | ||
| 118663806 | 11866380 | 6 | 20160601 | 0 | ||
| 118663806 | 11866380 | 7 | 20160719 | 0 | ||
| 118663806 | 11866380 | 8 | 20160824 | 0 |